Alector Inc. (ALEC) Financial Statements (2024 and earlier)

Company Profile

Business Address 131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO, CA 94080
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments712,851735,251413,308353,073
Cash and cash equivalents154,323329,15249,96989,641
Short-term investments558,528406,099363,339263,432
Other undisclosed current assets13,58414,4628,2034,364
Total current assets:726,435749,713421,511357,437
Noncurrent Assets
Operating lease, right-of-use asset27,81130,56932,47028,476
Property, plant and equipment25,52127,33030,18133,852
Restricted cash and investments1,4721,4721,4721,472
Other noncurrent assets6,4095,5742,617676
Total noncurrent assets:61,21364,94566,74064,476
TOTAL ASSETS:787,648814,658488,251421,913
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities31,96032,20925,54218,534
Accounts payable4,1894,7493,004278
Accrued liabilities27,77127,46022,53818,256
Deferred revenue48,23190,80323,88630,165
Debt    6,565
Other undisclosed current liabilities13,61816,54318,6606,706
Total current liabilities:93,809139,55568,08861,970
Noncurrent Liabilities
Long-term debt and lease obligation:  39,80643,74441,471
Liabilities, other than long-term debt479,397334,573108,889123,729
Deferred revenue443,370334,415108,417123,236
Other liabilities759158472493
Operating lease, liability35,26839,80643,74441,471
Other undisclosed noncurrent liabilities    
Total noncurrent liabilities:479,397374,379152,633165,200
Total liabilities:573,206513,934220,721227,170
Equity
Equity, attributable to parent214,442300,724267,530194,743
Common stock8887
Additional paid in capital798,696748,036676,956414,414
Accumulated other comprehensive income (loss)(4,575)(943)614142
Accumulated deficit(579,687)(446,377)(410,048)(219,820)
Total equity:214,442300,724267,530194,743
TOTAL LIABILITIES AND EQUITY:787,648814,658488,251421,913

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues133,617207,08521,09821,219
Gross profit:133,617207,08521,09821,219
Operating expenses(271,451)(244,445)(216,272)(135,623)
Operating loss:(137,834)(37,360)(195,174)(114,404)
Nonoperating income
(Other Nonoperating income)
7,7781,0314,9469,019
Loss from continuing operations before income taxes:(130,056)(36,329)(190,228)(105,385)
Income tax expense(3,254)   
Loss from continuing operations:(133,310)(36,329)(190,228)(105,385)
Loss before gain (loss) on sale of properties:(36,329)(190,228)(105,385)
Net loss available to common stockholders, diluted:(133,310)(36,329)(190,228)(105,385)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(133,310)(36,329)(190,228)(105,385)
Comprehensive loss:(133,310)(36,329)(190,228)(105,385)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3,632)(1,557)472184
Comprehensive loss, net of tax, attributable to parent:(136,942)(37,886)(189,756)(105,201)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: